Spruce Biosciences, Inc. (SPRB) News
Follow Spruce Biosciences, Inc. (SPRB) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 8 public stories across 7 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
Spruce Biosciences Price Target Maintained With a $144.00/Share by Citizens
Ratings actions from Benzinga
NEWS | Sep 24, 2026, 01:23 PM UTC
L
Spruce Biosciences CEO to present at H.C. Wainwright conference
Spruce Biosciences, Inc. said CEO Javier Szwarcberg will present at the H.C. Wainwright 28th Annual Global Investment Conference.
EQUITY | Sep 08, 2026, 08:05 PM UTC
L
Spruce Biosciences confirms TA-ERT BLA submission on track for Q4 2026
Spruce Biosciences says positive pre-BLA meetings with the FDA support its plan to submit a BLA for TA-ERT in Q4 2026.
REGULATION | Aug 24, 2026, 12:00 PM UTC
M
Spruce Biosciences confirms positive FDA pre-BLA meetings for ta-ert
Spruce Biosciences says its pre-BLA meetings with the FDA for ta-ert were positive and that its BLA submission remains on track for Q4 2026.
REGULATION | Aug 24, 2026, 12:00 PM UTC
H
SPRB: OPCO frames RARE’s accelerated Genglycos approval as positive
SPRB OPCO says yesterday’s accelerated approval of RARE’s Genglycos for GSD1a is a positive read for SPRB as TA-ERT approaches next quarter’s BLA submission.
EQUITY | Aug 21, 2026, 12:35 PM UTC
M
Spruce Biosciences Gets $5.5 Million Investment
SPRB Cure Sanfilippo Foundation and National MPS Society invest $5.5 million in Spruce Biosciences
MNA | Aug 12, 2026, 12:00 PM UTC
L
SPRB Spruce Biosciences Appoints Adrian Quartel, M.D., FFPM, as Chief Medical Officer Accomplished Rare Disease Drug Developer Brings More T
SPRB Spruce Biosciences Appoints Adrian Quartel, M.D., FFPM, as Chief Medical Officer Accomplished Rare Disease Drug Developer Brings More Than 25 Years of Global Clinical Development and Medical Affairs Leadership, Incl
EQUITY | Jul 27, 2026, 12:13 PM UTC
L
American Express, Biogen upgraded: Wall Street's top analyst calls
The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled. Top 5 Upgrades: JPMorgan upgraded American Express
EQUITY | Jul 13, 2026, 01:43 PM UTC